|
Salmanton-Garcia J, Marchesi F, Navratil M, Piukovics K, Del Principe MI, Criscuolo M, Bilgin YM, Fracchiolla NS, Vena A, Romano A, Falces-Romero I, Sgherza N, Heras-Fernando I, Biernat MM, Petzer V, Zak P, Weinbergerova B, Samarkos M, Erben N, van Praet J, Lopez-Garcia A, Labrador J, Lahmer T, Drgona L, Merelli M, Cuccaro A, Martin-Perez S, Davila-Valls J, Farina F, Cattaneo C, Pinczes LI, Magyari F, Espigado I, Buquicchio C, Vinh DC, Stoma I, Cernan M, Prezioso L, Papa MV, Plantefeve G, Khedr RA, Batinic J, Magliano G, Erdem S, Khostelidi S, Colovic N, Nappi D, Garcia-Ramirez P, Gora J, Callejas-Charavia M, Tlusty J, Bakker M, Wojtyniak E, Antic D, Magdziak A, Dargenio M, Idrizovic L, Pantic N, Stojanoski Z, Eisa N, Otasevic V, Marchetti M, Mackenzie E, Garcia-Vidal C, Aujayeb A, Almasari A, Miranda-Castillo C, Gavriilaki E, Coppola N, Busca A, Adzic-Vukicevic T, Schonlein M, Hersby DS, Grafe SK, Glenthoj A, Aiello TF, Cvetanoski M, Mitrovic M, Cerchione C, Prin R, Varricchio G, Arellano E, Cordoba R, Mayer J, Visek B, Wolf D, Anastasopoulou AN, Delia M, Musto P, Leotta D, Bavastro M, Limongelli A, Sciume M, van den Ven L, Fianchi L, Brunetti SC, Drozd-Sokolowska J, Dabrowska-Iwanicka A, Cornely OA, Pagano L. Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report. Am J Hematol. 2025 Mar;100(3):358-374. doi: 10.1002/ajh.27565. Epub 2024 Dec 23. PubMed PMID: 39715069; PubMed Central PMCID: PMC11803548.
AÑO: 2025; IF: 9.9
|
39715069
|
Jimenez-Vicente C, Esteve J, Baile-Gonzalez M, Perez-Lopez E, Martin Calvo C, Aparicio C, Oiartzabal Ormategi I, Esquirol A, Pena-Munoz F, Fernandez-Luis S, Heras Fernando I, Gonzalez-Rodriguez AP, Lopez-Garcia A, Lopez-Lorenzo JL, Torrado T, Saez Marin AJ, Acosta Fleytas C, Garcia L, Villar S, Filaferro S, Balsalobre P, Pascual Cascon MJ, Salas MQ. Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC). Blood Cancer J. 2025 Mar 21;15(1):42. doi: 10.1038/s41408-025-01223-x. PubMed PMID: 40118819; PubMed Central PMCID: PMC11928450.
AÑO: 2025; IF: 11.6
|
|
Chorao P, Avendano A, Heras I, Aiello F, Mico-Cerda M, Arrufat Bel A, Garcia-Gutierrez V, Olave MT, Gomez MA, Espigado I, Cuesta-Casas MA, Gonzalez-Santillana C, Hernandez-Rivas JA, Roldan-Perez A, Labrador J, Villalba M, Vazquez L, Garcia Vidal C, Martino R, Lopez-Jimenez J, Cedillo A, Solano C, Garcia-Cadenas I, Pinana JL; Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation Cell Therapy Group (GETH-TC). Co-infections during SARS-CoV-2 infection in hematologic patients and cell therapy recipients in the omicron era: a Spanish hematopoietic stem cell transplantation and cell therapy group study. BMC Infect Dis. 2025 Jul 25;25(1):944. doi: 10.1186/s12879-025-11302-w. PubMed PMID: 40713537; PubMed Central PMCID: PMC12291501.
AÑO: 2025; IF: 3.0
|
|
Gimenez E, Cadenas IG, Pinana JL, Albert E, Vazquez L, Avendano A, Cabrero M, Esquirol A, Martino R, Lopez-Jimenez J, Cuesta MA, Humala K, Villar S, Rovira M, Heras I, Zudaire T, Arroyo I, Zabalza A, Aguado B, Solano C, Navarro D; Spanish Group for Hematopoietic Transplantation (GETH). Cytomegalovirus DNA Doubling Time for Early Identification of Clinically Significant Infection Episodes in Allogeneic Hematopoietic Stem Cell Transplant Recipients Undergoing Primary Letermovir Prophylaxis: A Multicenter Study. Transpl Infect Dis. 2025 Jul 17:e70080. doi: 10.1111/tid.70080. Online ahead of print. PubMed PMID: 40674366.
AÑO: 2025; IF: 2.6
|
|
Kwon M, Gomez-Centurion I, Oarbeascoa G, Torres M, Martinez AP, Suarez-Lledo M, Chinea A, Cascon MJP, Vazquez L, Espigado I, Izquierdo I, Parody R, Cadenas IG, Calbacho M, Sierra PG, Heras I, Yanez L, Torrent A, Bautista G, Gonzalez S, Roldan E, Vallejo JC, Bailen R, Borrero A, Lopez-Jimenez J, Casas MAC, Solano C; Spanish Group of Hematopoietic Stem Cell Transplantation and Cell Therapy (GETH-TC). Real-World Experience with Isavuconazole in Allogeneic Stem Cell Transplantation in Spain. Transplant Cell Ther. 2024 Oct;30(10):1033.e1-1033.e8. doi: 10.1016/j.jtct.2024.06.009. Epub 2024 Jun 12. PubMed PMID: 38871055.
AÑO: 2024; IF: 4.4
|